Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Dodick

Showing results (141-150 of 431) with videos related to

Pageof 44
Sort By:
Headache|February 27, 2003
Clinical, anatomical, and physiologic relationship between sleep and headacheDavid W Dodick, Eric J Eross, James M Parish, et al.
The Lancet. Neurology|September 20, 2025
Spreading brain health awarenessTissa Wijeratne, David W Dodick, Steven L Lewis, et al.
BMC Neurology|October 26, 2022
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studiesPatricia Pozo-Rosich, David W Dodick, Anders Ettrup, et al.
Pain Physician|September 20, 2011
Occipital nerve stimulation with the Bion® microstimulator for the treatment of medically refractory chronic cluster headacheNatalie H Strand, Terrence L Trentman, Bert B Vargas, et al.
The Lancet. Neurology|July 21, 2024
World Brain Day 2024: a focus on brain health and preventionWolfgang Grisold, David W Dodick, Alla Guekht, et al.
Headache|January 31, 2019
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine HeadachesStewart J Tepper, David W Dodick, Peter C Schmidt, et al.
CNS Drugs|December 8, 2004
Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tabletEgilius L H Spierings, Alan M Rapoport, David W Dodick, et al.
Cephalalgia : an International Journal of Headache|October 13, 2010
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptanDavid W Dodick, James Kost, Christopher Assaid, et al.
Eneurologicalsci|May 30, 2023
Advocacy for patients with headache disordersRiadh Gouider, Deborah Henscheid Lorenz, Audrey Craven, et al.
Medical Devices (Auckland, N.Z.)|April 8, 2014
Refractory headaches treated with bilateral occipital and temporal region stimulationKelly J Zach, Terrence L Trentman, Richard S Zimmerman, et al.
Pageof 44

Showing results (141-150 of 431) with videos related to

Sort By:
Pageof 44
Headache|February 27, 2003
Clinical, anatomical, and physiologic relationship between sleep and headacheDavid W Dodick, Eric J Eross, James M Parish, et al.
The Lancet. Neurology|September 20, 2025
Spreading brain health awarenessTissa Wijeratne, David W Dodick, Steven L Lewis, et al.
BMC Neurology|October 26, 2022
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studiesPatricia Pozo-Rosich, David W Dodick, Anders Ettrup, et al.
Pain Physician|September 20, 2011
Occipital nerve stimulation with the Bion® microstimulator for the treatment of medically refractory chronic cluster headacheNatalie H Strand, Terrence L Trentman, Bert B Vargas, et al.
The Lancet. Neurology|July 21, 2024
World Brain Day 2024: a focus on brain health and preventionWolfgang Grisold, David W Dodick, Alla Guekht, et al.
Headache|January 31, 2019
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine HeadachesStewart J Tepper, David W Dodick, Peter C Schmidt, et al.
CNS Drugs|December 8, 2004
Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tabletEgilius L H Spierings, Alan M Rapoport, David W Dodick, et al.
Cephalalgia : an International Journal of Headache|October 13, 2010
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptanDavid W Dodick, James Kost, Christopher Assaid, et al.
Eneurologicalsci|May 30, 2023
Advocacy for patients with headache disordersRiadh Gouider, Deborah Henscheid Lorenz, Audrey Craven, et al.
Medical Devices (Auckland, N.Z.)|April 8, 2014
Refractory headaches treated with bilateral occipital and temporal region stimulationKelly J Zach, Terrence L Trentman, Richard S Zimmerman, et al.
Pageof 44